Friday, Jan 28, 2022
Outlook.com

Bharat Biotech's New Plant Dispatches First Commercial Batch Of Covaxin

The government had earlier this month given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.

Bharat Biotech's New Plant Dispatches First Commercial Batch Of Covaxin
Representational Image -

In presence of Union Health Minister Mansukh Mandaviya, Bharat Biotech's new plant at Gujrat's Ankleshwar dispatched their first commercial batch of Covaxin on Sunday.  

"Vaccination is the most important thing to strengthen the country's fight against coronavirus.Released the first commercial batch of #COVAXIN from Bharat Biotech's plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in the country and will help the vaccine reach every Indian," Mandaviya tweeted soon after the event.

The new plant got government's approval  earlier this month in a bid to ramp up to production of the anti-COVID-19 vaccine Covaxin.

In May, Bharat Biotech announced that it planned to produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility. The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit, Chiron Behring, to add another 200 million doses of Covaxin.

India administered 63.09 crore doses of COVID-19 vaccination in a nationwide drive till Sunday morning, as per the data released by the Union Health Ministry.

(With PTI Inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement